신경학적 바이오마커용 면역측정법 시장 : 제품 유형별, 질환별, 최종사용자별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Immunoassay for Neurological Biomarkers Market size was valued at USD 1,090.3 Million in 2025, expanding to a CAGR of 9.1% from 2026 to 2033.

Immunoassays for neurological biomarkers are advanced analytical testing methods that leverage highly specific antigen-antibody interactions to identify and quantify biomarkers linked to neurological disorders. These assays play a critical role in the diagnosis, disease monitoring, prognosis, and therapeutic assessment of various neurological conditions, enabling clinicians and researchers to gain valuable insights on diseases.

Immunoassay for Neurological Biomarkers Market- Market Dynamics

Growing prevalence of neurological disorders and advancement in biomarker testing are expected to propel market demand

The global immunoassay for neurological biomarkers market is experiencing significant growth owing to the rising prevalence of neurodegenerative and neurological disorders worldwide. The market is driven by the increase in prevalence of diseases like Alzheimer's disease, sclerosis, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and various types of dementia. Immunoassays are often essential in the early detection of disease-associated biomarkers, often preceding the development of major clinical symptoms. Continued improvements in assay sensitivity, the ability to perform multiplex testing and detection of blood-based biomarkers are also driving market growth. Market demand is also driven by the growing availability of minimally invasive testing.

Another important factor driving the market growth is the continuous development of immunoassay technologies and the increasing acceptance of precision medicine in the neurological care. Growing investments in neuroscience studies, biomarker discovery and validation programs and companion diagnostic development are encouraging innovation across the industry. Key market trends include increasing commercialization of blood-based diagnostic tests for Alzheimer's disease, multiple immunoassay platforms to analyze multiple biomarkers from a single sample. These innovations are improving diagnostic accuracy, simplifying clinical decision making, reducing testing complexity and enabling broader implementation of neurological biomarker testing in healthcare facilities, diagnostic laboratories etc. Furthermore, rising investments in the research of neuroscience, biomarker tests are also augmenting the market growth. Thus, sophisticated immunoassays are increasingly important for disease stratification in neurological disorders.

Immunoassay for Neurological Biomarkers Market- Segmentation Analysis:

The Global Immunoassay for Neurological Biomarkers Market is segmented on the basis of Product Type, Disease, End User, and Region.

The market is divided into four categories based on Disease: Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. Alzheimer's disease accounts for the substantial share of the immunoassay for neurological biomarkers market owing to its high prevalence across the globe. Further, increasing healthcare spending and developments immunoassay technologies is accelerating Alzheimer disease segment demand.

Immunoassay for Neurological Biomarkers Market- Geographical Insights

The Asia-Pacific region is one of the fastest growing markets for immunoassays in neurological biomarker testing. The growth is driven by increasing healthcare spending, rising prevalence of neurological diseases, and continued investment in diagnostic and research infrastructure. China, Japan, South Korea and India are all actively developing their neuroscience study programs, improving clinical diagnostic capabilities and access to cutting-edge biomarker testing technologies. The market growth is also driven by the region's rapidly aging population, rising awareness about neurodegenerative diseases, and increasing focus on early diagnosis and preventive healthcare. North America continues to be a leading market, supported by a strong healthcare infrastructure, significant investment in neurological research, and early adoption of advanced diagnostic solutions. The presence of leading biotechnology and diagnostics companies, strong government and private-sector funding, and growing utilization of biomarker-based testing for conditions such as Alzheimer's disease and Parkinson's disease continue to support market expansion across the region.

U.S. Immunoassay for Neurological Biomarkers Market- Key Insights

The United States is an important market for immunoassays for neurological biomarkers testing, due to the country's strong biotechnology industry, a well-developed neuroscience study environment and early adoption of innovative diagnostic solutions. The increasing prevalence of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurodegenerative diseases is driving the demand for highly accurate and minimally invasive biomarker-based diagnostic solutions. Healthcare organizations and clinicians are increasingly using biomarker testing to help detect disease earlier and improve diagnosis.

Immunoassay for Neurological Biomarkers Market- Competitive Landscape:

The immunoassay for neurological biomarkers market is characterized by intense competition, with major diagnostics manufacturers, life sciences companies, and biotechnology firms focusing on enhancing assay accuracy. Industry participants are making significant investments in research and development to identify novel neurological biomarkers, improve analytical performance, etc. In addition, strategic partnerships and collaborations with pharmaceutical companies, research institutes is fueling market growth. These strategic initiatives are helping market players strengthen their competitive positions while expanding the clinical utility of neurological biomarker testing.

Recent Developments:

In January 2025, Roche expanded its neurological diagnostics portfolio by introducing advanced blood-based biomarker testing solutions aimed at improving the early identification, diagnosis, etc.

In June 2025, Abbott Laboratories boosted its immunodiagnostics portfolio through enhancements to automated neurological biomarker testing capabilities, aiding improved laboratory efficiency, and advanced diagnostic solutions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS

• Roche Diagnostics
• Siemens Healthineers
• Fujirebio
• Quanterix Corporation
• Revvity, Inc.
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Sysmex Corporation
• Becton, Dickinson and Company (BD)
• Agilent Technologies, Inc.
• Bio-Techne Corporation
• QIAGEN
• Diasorin S.p.A.
• Beckman Coulter, Inc. (Danaher)
• Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033

• Instruments
• Reagents
• Services

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE- MARKET ANALYSIS, 2020-2033

• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Traumatic Brain Injury (TBI)
• Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2020-2033

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Immunoassay for Neurological Biomarkers Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
• 2.2. Competitive Insights

3. Immunoassay for Neurological Biomarkers Key Market Trends

• 3.1. Immunoassay for Neurological Biomarkers Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Immunoassay for Neurological Biomarkers Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Immunoassay for Neurological Biomarkers Market Opportunities
• 3.4. Immunoassay for Neurological Biomarkers Market Future Trends

4. Immunoassay for Neurological Biomarkers Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Immunoassay for Neurological Biomarkers Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Immunoassay for Neurological Biomarkers Market Landscape

• 6.1. Immunoassay for Neurological Biomarkers Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Immunoassay for Neurological Biomarkers Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
  • 7.1.2. Instruments
  • 7.1.3. Reagents
  • 7.1.4. Services

8. Immunoassay for Neurological Biomarkers Market - By Disease

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
  • 8.1.2. Alzheimer's Disease
  • 8.1.3. Parkinson's Disease
  • 8.1.4. Multiple Sclerosis
  • 8.1.5. Traumatic Brain Injury (TBI)
  • 8.1.6. Others

9. Immunoassay for Neurological Biomarkers Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Diagnostic Laboratories
  • 9.1.4. Research Institutes
  • 9.1.5. Others

10. Immunoassay for Neurological Biomarkers Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Immunoassay for Neurological Biomarkers Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.8.4. UK Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.9.4. France Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.10.4. Italy Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.11.4. Spain Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.14.4. Russia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.16. Denmark
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.16.4. Denmark Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3.17. Rest of Europe
    • 10.3.17.1. Overview
    • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.4.5. APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.7.4. China Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.8.4. India Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.13.4. Thailand Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.15. Taiwan
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.15.4. Taiwan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.16. Vietnam
    • 10.4.16.1. Overview
    • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.16.4. Vietnam Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4.17. Rest of APAC
    • 10.4.17.1. Overview
    • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.17.4. Rest of APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.5.5. LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.6.5. MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.8.4. UAE Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.13. Iran
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.13.4. Iran Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.14. Qatar
    • 10.6.14.1. Overview
    • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.14.4. Qatar Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6.15. Rest of MEA
    • 10.6.15.1. Overview
    • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.15.4. Rest of MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Immunoassay for Neurological Biomarkers Industry

• 11.1. Competitive Benchmarking
  • 11.1.1. Competitive Dashboard
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Roche Diagnostics
  • 11.2.2. Siemens Healthineers
  • 11.2.3. Fujirebio
  • 11.2.4. Quanterix Corporation
  • 11.2.5. Revvity, Inc.
  • 11.2.6. Abbott Laboratories
  • 11.2.7. Bio-Rad Laboratories, Inc.
  • 11.2.8. Thermo Fisher Scientific Inc.
  • 11.2.9. Sysmex Corporation
  • 11.2.10. Becton, Dickinson and Company (BD)
  • 11.2.11. Agilent Technologies, Inc.
  • 11.2.12. Bio-Techne Corporation
  • 11.2.13. QIAGEN
  • 11.2.14. Diasorin S.p.A.
  • 11.2.15. Beckman Coulter, Inc. (Danaher)
  • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us